Joye1/66fan/Gcbr...Speaking of seriousguy, he fits into this as well. It was last November and December that he was CERTAIN that a deal had been done. He finally became a little frustrated, saying he didn't understand the DNAP PR department.
Well, and Arch, your post fits into this as well. One of the problems with DNAP's science is that it is not ON the cutting edge, it IS the cutting edge. Yet, in order for a significant deal to be consummated, the parties to the deal/deals, even DNAP, would need some assurance that what they are buying is verifiable and validated. It would also be in the best interests of both sides to have an independent party investigate the product(s) market potential to establish the value of the property under discussion, assuming it validated.
That's why I find it significant that the three musketeers, Gabriel, Gomez, and Bookbinder, all three Managing Partners in Genbiomics, find themselves in the Bio/Pharma validation arm of Semaphore in November 2002. The next thing you know, wham, they are deeply involved in the inner workings of DNAP, and seem to be transforming the organization.
I thought that sample project from Semaphore's website was very instructive. A company with patents pending and provisional patents who needs an independent party to verify and validate the science prior to the "event". Sounded alot like what would need to happen here in order to complete a deal.
The other thing I find very curious, and I know there are those that are all worked up about funding over on the main board, but they have NOT sold shares during the big run here. They certainly have the shares, and the price is such that they could get pretty significant funding using relatively few shares, yet they have not chosen that route.
The stated purpose of the contract they signed with Genbiomics was to source capital for the company. That deal was to have run until 12/31/2005 but has been cancelled. For a company that is supposedly "desperately" in need of capital, as some would suggest, they seem to have let go of a couple of good opportunities.
Of course, it's all speculation at this point, but it's damned interesting speculation. And I personally think we are getting pretty close to finding out what's really up at DNAP.
One last thing, I tried several times to get my original post with the example deal and the Semaphore PR to post over on the main board last night...nothing doing...oh well LOL
Later,
W2P
